GAVIX

INGREDIENT COMPONENTS OF MEDICINE:

Clopidogrel (in the form of clopidogrel bisulfat) ........................ 75 mg

Excipients q.s ... .....................1 member

Manitol, microcrystallin cellulose M101, povidone K30, low - substituted hydroxypropyl cellulose (L-HPC (LH21)), hydrogenated castor oil, talc, hypromellose 2910 (6cp), hypromellose 2910 (15cp), polyethylene glycol 6000, titanium dioxide, iron oxide red).

DOSAGE FORM: Film-coated tablets.

PHARMACODYNAMIC:

ATC Code: B01AC04

Gavix, whose main active ingredient is clopidogrel, is a selective inhibitor of adenosine diphosphate (ADP) binding to its platelet receptor, thereby inhibiting ADP mediated activation of the glycoprotein GPIIb complex. / IIIa, thereby inhibiting platelet aggregation. The metabolism of clopidogrel is necessary for the inhibition of platelet aggregation. In addition to blocking the amplification of platelet activation from ADP release, clopidogrel also inhibits platelet aggregation due to synergies elsewhere. Clopidogrel acts by irreversibly altering platelet ADP receptors. Consequently, clopidogrel-attached platelets will affect the later stages of platelet life. The inhibition of platelet aggregation is dose-dependent, which can be seen after 2 hours of a single dose. Platelet aggregation and bleeding time returned to baseline values by hiccups, usually within 5 days after stopping treatment.

PHARMACOKINETICS: After repeated oral administration of 75 mg / day, clopidogrel is rapidly absorbed and metabolized primarily in the liver into two forms: active (thiol derivatives) and inactive (carboxylic acid derivatives) ). Thiol metabolites bind quickly and irreversibly to platelet ADP receptors. This metabolite is not detectable in plasma. Carboxylic acid derivatives account for 85% of the drug component circulating in plasma. The elimination half-life of the major circulating metabolite is 8 hours after single and repeated doses. About 50% of the drug is excreted in the urine and 46% in the feces for about 120 hours after dosing.

PRESENTATION: Box of 1 blister x 14 tablets.

POINT:

Reduces the risk of arterial thrombotic events in:

- Patients with myocardial infarction (from a few days to less than 35 days), ischemic stroke (from 7 days to less than 6 months) or established peripheral artery disease.

- Patients with acute coronary syndrome: Acute coronary syndrome with no ST segment elevation (unstable angina or non-Q-wave myocardial infarction) and acute myocardial infarction with ST segment swell, use aspirin in combination.

DOSAGE AND ADMINISTRATION:

Adults and elderly: 1 tablet (75 mg) / day. Can be taken with or without meals. No dosage adjustment is needed for the elderly or patients with kidney disease.

In patients with acute coronary syndrome with no ST segment elevation: first 4 tablets (300 mg), then continue at a dose of 75 mg / day (in combination with aspirin 75 - 325 mg) in subsequent days follow.

There are no data on the safety and efficacy of drugs for patients under 18 years of age.

CONTRAINDICATIONS: Hypersensitivity to the drug components. Bleeding due to active pathology such as gastroduodenal bleeding, retinal hemorrhage or intracranial. Severe liver failure

PRECAUTIONS: Patients at risk of bleeding due to trauma, surgery or other bleeding pathologies (such as ulcers). Discontinue the medicine 7 days before surgery. Stop taking the medicine when there is unusual bleeding (and tell the doctor right away).

Patients with renal insufficiency, liver disease.

Pregnant and lactating women:

Clopidogrel is not recommended during pregnancy because there are no adequate and well-controlled studies in pregnant women.

It is not known whether clopidogrel is excreted in human milk or not, so do not use the drug while breastfeeding.

Effects of drugs on work:

Clopidogrel does not affect machinery operators, train drivers, people working on high altitude and other cases.

INTERACTIONS: Precautions clopidogrel in combination with aspirin, nonsteroidal anti-inflammatory drugs, heparin, thrombolytic drugs. Clopidogrel and warfarin should not be used in combination.

ADVERSE EFFECTS: Gastrointestinal bleeding, intracranial hemorrhage, hematoma, epistaxis, haematuria, eye bleeding, abdominal pain, anorexia, diarrhea, constipation, vomiting, rash, itching.

Inform your doctor unwanted effects encountered when using the drug.

OVERDOSE AND TREATMENT:

No adverse effects have been reported following a single dose of 600 mg of clopidogrel. Bleeding time increased by 1.7 times compared with 75 mg / day dose. There is no antidote clopidogrel yet. Platelet transfusion may limit the effects of clopidogrel.

Read the directions carefully before use.

This drug is for a doctor's prescription.

SHELF LIFE: 36 months from date of manufacture.

STORAGE CONDITIONS:

Store in dry places, not exceeding 30^oC, protect from light.

DATE OF CONSIDERATION OF AMENDMENTS AND UPDATED CONTENTS OF DRUGS GUIDANCE: November 7, 2017

Read the directions carefully before use.

Keep out of reach of CHILDREN.

Immediately inform your doctor or pharmacist of any unwanted effects encountered when using the drug.

This drug is for a doctor's prescription.

INGREDIENT, CONTENT OF MEDICINE:

Clopidogrel (as clopidogrel bisulfat) .................... 75 mg

Excipients q.s ... ................ 1 member

(Manitol, microcrystallin cellulose M101, povidone K30, low - substituted hydroxypropyl cellulose (L-HPC (LH21)), hydrogenated castor oil, talc, hypromellose 2910 (6cp), hypromellose 2910 (15cp), polyethylene glycol 6000, titanium dioxide, oxide red iron).

PRODUCT DESCRIPTION:

Film-coated tablets are light pink, one side is smooth, the other is heart-shaped, the sides and members are smooth.

PRESENTATION: Box of 1 blister x 14 tablets.

WHAT IS THE MEDICINE USED FOR:

Reduces the risk of arterial thrombotic events in:

- Patients with myocardial infarction (from a few days to less than 35 days), ischemic stroke (from 7 days to less than 6 months) or established peripheral artery disease.

HOW TO USE THIS MEDICINE AND DOSAGE:

Oral administration.

Adults and elderly: 1 tablet (75 mg) / day. Can be taken with or without meals. No dosage adjustment is needed for the elderly or patients with kidney disease.

In patients with acute coronary syndrome with no ST segment elevation: first 4 tablets (300 mg), then continue at 75 mg / day (in combination with aspirin 75-325 mg) in subsequent days follow.

There are no data on the safety and efficacy of drugs for patients under 18 years of age.

Or as directed by a physician.

WHEN SHOULD NOT TAKE THIS MEDICINE:

Hypersensitivity to the drug component. Bleeding due to active pathology such as gastroduodenal bleeding, or retinal hemorrhage

intracranial.

Severe liver failure

UNWANTED EFFECTS:

Gastrointestinal bleeding, intracranial hemorrhage, hematoma, epistaxis, haematuria, eye bleeding, abdominal pain, anorexia, diarrhea, constipation, vomiting, rash, itching.

Immediately inform your doctor or pharmacist of any unwanted effects encountered when using the drug.

WHAT DRUGS OR FOOD AVOIDES AVOID TO AVOID WHEN USING THIS MEDICINE:

Use caution when using clopidogrel in combination with aspirin, nonsteroidal anti-inflammatory drugs, heparin, thrombolytic drugs.

Clopidogrel and warfarin should not be used in combination.

What to do when you forget to use drugs:

Take the next dose as directed. Do not use extra medicine to make up the missed dose to avoid overdose.

HOW TO STORAGE THIS MEDICINE:

Store in dry places, not exceeding 30^oC, protect from light.

SIGNS AND SYMPTOMS WHEN USING OVERDOSE DRUGS: No side effects have been reported after a single dose of 600 mg of clopidogrel. Bleeding time increased by 1.7 times compared with 75 mg / day dose.

WHAT TO DO WHEN USING DRUGS TOO MUCH RECOMMENDED: There is no antidote clopidogrel. Platelet transfusion may limit the effects of clopidogrel.

IMPORTANT THINGS WHEN USING THIS MEDICINE:

Patients at risk of bleeding from trauma, surgery or other bleeding pathologies (such as ulcers). Discontinue the medicine 7 days before surgery. Stop taking the medicine when there is unusual bleeding and notify the doctor immediately.

Patients with renal insufficiency, liver disease.

Pregnant and lactating women: Clopidogrel is not recommended during pregnancy because there are no adequate and well-controlled studies in pregnant women.

It is not known whether clopidogrel is excreted in human milk or not, so do not use the drug while breastfeeding.

Effects of drugs on work: Clopidogrel has no effect on machine operators, driving trains, people working on high altitude and other cases.

WHEN TO CONSULT DOCTOR AND PHARMACY:

If you need further information, please consult your doctor or pharmacist.

SHELF-LIFE OF MEDICINE: 36 months from date of manufacture.

DATE OF CONSIDERATION OF AMENDMENTS AND UPDATED CONTENTS OF DRUGS GUIDANCE: November 7, 2017

{"id":3567003,"name":"GAVIX","desc":"Reduces the risk of arterial thrombotic events.<\/p>\n","content":"INGREDIENT COMPONENTS OF MEDICINE:<\/strong><\/p>\n\nClopidogrel (in the form of clopidogrel bisulfat) ........................ 75 mg<\/p>\n\nExcipients q.s ... .....................1 member<\/p>\n\nManitol, microcrystallin cellulose M101, povidone K30, low - substituted hydroxypropyl cellulose (L-HPC (LH21)), hydrogenated castor oil, talc, hypromellose 2910 (6cp), hypromellose 2910 (15cp), polyethylene glycol 6000, titanium dioxide, iron oxide red).<\/p>\n\nDOSAGE FORM:<\/strong> Film-coated tablets.<\/p>\n\nPHARMACODYNAMIC:<\/strong><\/p>\n\nATC Code: B01AC04<\/p>\n\nGavix, whose main active ingredient is clopidogrel, is a selective inhibitor of adenosine diphosphate (ADP) binding to its platelet receptor, thereby inhibiting ADP mediated activation of the glycoprotein GPIIb complex. \/ IIIa, thereby inhibiting platelet aggregation. The metabolism of clopidogrel is necessary for the inhibition of platelet aggregation. In addition to blocking the amplification of platelet activation from ADP release, clopidogrel also inhibits platelet aggregation due to synergies elsewhere. Clopidogrel acts by irreversibly altering platelet ADP receptors. Consequently, clopidogrel-attached platelets will affect the later stages of platelet life. The inhibition of platelet aggregation is dose-dependent, which can be seen after 2 hours of a single dose. Platelet aggregation and bleeding time returned to baseline values by hiccups, usually within 5 days after stopping treatment.<\/p>\n\nPHARMACOKINETICS:<\/strong> After repeated oral administration of 75 mg \/ day, clopidogrel is rapidly absorbed and metabolized primarily in the liver into two forms: active (thiol derivatives) and inactive (carboxylic acid derivatives) ). Thiol metabolites bind quickly and irreversibly to platelet ADP receptors. This metabolite is not detectable in plasma. Carboxylic acid derivatives account for 85% of the drug component circulating in plasma. The elimination half-life of the major circulating metabolite is 8 hours after single and repeated doses. About 50% of the drug is excreted in the urine and 46% in the feces for about 120 hours after dosing.<\/p>\n\nPRESENTATION:<\/strong> Box of 1 blister x 14 tablets.<\/p>\n\nPOINT:<\/strong><\/p>\n\nReduces the risk of arterial thrombotic events in:<\/p>\n\n- Patients with myocardial infarction (from a few days to less than 35 days), ischemic stroke (from 7 days to less than 6 months) or established peripheral artery disease.<\/p>\n\n- Patients with acute coronary syndrome: Acute coronary syndrome with no ST segment elevation (unstable angina or non-Q-wave myocardial infarction) and acute myocardial infarction with ST segment swell, use aspirin in combination.<\/p>\n\nDOSAGE AND ADMINISTRATION:<\/strong><\/p>\n\nAdults and elderly:<\/em> 1 tablet (75 mg) \/ day. Can be taken with or without meals. No dosage adjustment is needed for the elderly or patients with kidney disease.<\/p>\n\nIn patients with acute coronary syndrome with no ST segment elevation: first 4 tablets (300 mg), then continue at a dose of 75 mg \/ day (in combination with aspirin 75 - 325 mg) in subsequent days follow.<\/p>\n\nThere are no data on the safety and efficacy of drugs for patients under 18 years of age.<\/p>\n\nCONTRAINDICATIONS:<\/strong> Hypersensitivity to the drug components. Bleeding due to active pathology such as gastroduodenal bleeding, retinal hemorrhage or intracranial. Severe liver failure<\/p>\n\nPRECAUTIONS:<\/strong> Patients at risk of bleeding due to trauma, surgery or other bleeding pathologies (such as ulcers). Discontinue the medicine 7 days before surgery. Stop taking the medicine when there is unusual bleeding (and tell the doctor right away).<\/p>\n\nPatients with renal insufficiency, liver disease.<\/p>\n\nPregnant and lactating women:<\/em><\/p>\n\nClopidogrel is not recommended during pregnancy because there are no adequate and well-controlled studies in pregnant women.<\/p>\n\nIt is not known whether clopidogrel is excreted in human milk or not, so do not use the drug while breastfeeding.<\/p>\n\nEffects of drugs on work:<\/p>\n\nClopidogrel does not affect machinery operators, train drivers, people working on high altitude and other cases.<\/p>\n\nINTERACTIONS:<\/strong> Precautions clopidogrel in combination with aspirin, nonsteroidal anti-inflammatory drugs, heparin, thrombolytic drugs. Clopidogrel and warfarin should not be used in combination.<\/p>\n\nADVERSE EFFECTS:<\/strong> Gastrointestinal bleeding, intracranial hemorrhage, hematoma, epistaxis, haematuria, eye bleeding, abdominal pain, anorexia, diarrhea, constipation, vomiting, rash, itching.<\/p>\n\nInform your doctor unwanted effects encountered when using the drug.<\/p>\n\nOVERDOSE AND TREATMENT:<\/strong><\/p>\n\nNo adverse effects have been reported following a single dose of 600 mg of clopidogrel. Bleeding time increased by 1.7 times compared with 75 mg \/ day dose. There is no antidote clopidogrel yet. Platelet transfusion may limit the effects of clopidogrel.<\/p>\n\nRead the directions carefully before use.<\/p>\n\nThis drug is for a doctor&#39;s prescription.<\/p>\n\nSHELF LIFE:<\/strong> 36 months from date of manufacture.<\/p>\n\nSTORAGE CONDITIONS:<\/strong><\/p>\n\nStore in dry places, not exceeding 30o<\/sup>C, protect from light.<\/p>\n\nDATE OF CONSIDERATION OF AMENDMENTS AND UPDATED CONTENTS OF DRUGS GUIDANCE: November 7, 2017<\/strong><\/p>\n\nRead the directions carefully before use.<\/p>\n\nKeep out of reach of CHILDREN.<\/p>\n\nImmediately inform your doctor or pharmacist of any unwanted effects encountered when using the drug.<\/p>\n\nThis drug is for a doctor&#39;s prescription.<\/p>\n\nINGREDIENT, CONTENT OF MEDICINE:<\/strong><\/p>\n\nClopidogrel (as clopidogrel bisulfat) .................... 75 mg<\/p>\n\nExcipients q.s ... ................ 1 member<\/p>\n\n(Manitol, microcrystallin cellulose M101, povidone K30, low - substituted hydroxypropyl cellulose (L-HPC (LH21)), hydrogenated castor oil, talc, hypromellose 2910 (6cp), hypromellose 2910 (15cp), polyethylene glycol 6000, titanium dioxide, oxide red iron).<\/p>\n\nPRODUCT DESCRIPTION:<\/strong><\/p>\n\nFilm-coated tablets are light pink, one side is smooth, the other is heart-shaped, the sides and members are smooth.<\/p>\n\nPRESENTATION:<\/strong> Box of 1 blister x 14 tablets.<\/p>\n\nWHAT IS THE MEDICINE USED FOR:<\/strong><\/p>\n\nReduces the risk of arterial thrombotic events in:<\/p>\n\n- Patients with myocardial infarction (from a few days to less than 35 days), ischemic stroke (from 7 days to less than 6 months) or established peripheral artery disease.<\/p>\n\n- Patients with acute coronary syndrome: Acute coronary syndrome with no ST segment elevation (unstable angina or non-Q-wave myocardial infarction) and acute myocardial infarction with ST segment swell, use aspirin in combination.<\/p>\n\nHOW TO USE THIS MEDICINE AND DOSAGE:<\/strong><\/p>\n\nOral administration.<\/p>\n\nAdults and elderly:<\/em> 1 tablet (75 mg) \/ day. Can be taken with or without meals. No dosage adjustment is needed for the elderly or patients with kidney disease.<\/p>\n\nIn patients with acute coronary syndrome with no ST segment elevation: first 4 tablets (300 mg), then continue at 75 mg \/ day (in combination with aspirin 75-325 mg) in subsequent days follow.<\/p>\n\nThere are no data on the safety and efficacy of drugs for patients under 18 years of age.<\/p>\n\nOr as directed by a physician.<\/p>\n\nWHEN SHOULD NOT TAKE THIS MEDICINE:<\/strong><\/p>\n\nHypersensitivity to the drug component. Bleeding due to active pathology such as gastroduodenal bleeding, or retinal hemorrhage<\/p>\n\nintracranial.<\/p>\n\nSevere liver failure<\/p>\n\nUNWANTED EFFECTS:<\/strong><\/p>\n\nGastrointestinal bleeding, intracranial hemorrhage, hematoma, epistaxis, haematuria, eye bleeding, abdominal pain, anorexia, diarrhea, constipation, vomiting, rash, itching.<\/p>\n\nImmediately inform your doctor or pharmacist of any unwanted effects encountered when using the drug.<\/p>\n\nWHAT DRUGS OR FOOD AVOIDES AVOID TO AVOID WHEN USING THIS MEDICINE:<\/strong><\/p>\n\nUse caution when using clopidogrel in combination with aspirin, nonsteroidal anti-inflammatory drugs, heparin, thrombolytic drugs.<\/p>\n\nClopidogrel and warfarin should not be used in combination.<\/p>\n\nWhat to do when you forget to use drugs:<\/p>\n\nTake the next dose as directed. Do not use extra medicine to make up the missed dose to avoid overdose.<\/p>\n\nHOW TO STORAGE THIS MEDICINE:<\/strong><\/p>\n\nStore in dry places, not exceeding 30o<\/sup>C, protect from light.<\/p>\n\nSIGNS AND SYMPTOMS WHEN USING OVERDOSE DRUGS:<\/strong> No side effects have been reported after a single dose of 600 mg of clopidogrel. Bleeding time increased by 1.7 times compared with 75 mg \/ day dose.<\/p>\n\nWHAT TO DO WHEN USING DRUGS TOO MUCH RECOMMENDED:<\/strong> There is no antidote clopidogrel. Platelet transfusion may limit the effects of clopidogrel.<\/p>\n\nIMPORTANT THINGS WHEN USING THIS MEDICINE:<\/strong><\/p>\n\nPatients at risk of bleeding from trauma, surgery or other bleeding pathologies (such as ulcers). Discontinue the medicine 7 days before surgery. Stop taking the medicine when there is unusual bleeding and notify the doctor immediately.<\/p>\n\nPatients with renal insufficiency, liver disease.<\/p>\n\nPregnant and lactating women:<\/em> Clopidogrel is not recommended during pregnancy because there are no adequate and well-controlled studies in pregnant women.<\/p>\n\nIt is not known whether clopidogrel is excreted in human milk or not, so do not use the drug while breastfeeding.<\/p>\n\nEffects of drugs on work:<\/em> Clopidogrel has no effect on machine operators, driving trains, people working on high altitude and other cases.<\/p>\n\nWHEN TO CONSULT DOCTOR AND PHARMACY:<\/strong><\/p>\n\nIf you need further information, please consult your doctor or pharmacist.<\/p>\n\nSHELF-LIFE OF MEDICINE:<\/strong> 36 months from date of manufacture.<\/p>\n\nDATE OF CONSIDERATION OF AMENDMENTS AND UPDATED CONTENTS OF DRUGS GUIDANCE: November 7, 2017<\/strong><\/p>\n","image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/gavix.jpg?t=1600937042","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/product\/gavix.jpg?t=1601610198","tags":["gavix","heart attack","acute coronary artery"],"count_view":559,"seo_name":"gavix-eng","date_update":"1744701789","date_created_format":"","meta_title":"","meta_desc":"","meta_keyword":"","sku":"SKU-3010975","code":"8935206008982","rate":0,"image_2_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/gavix.jpg?t=1600937042","image_2_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/product\/gavix.jpg?t=1601610198","time_promotion":false,"date_sale":[],"status_order":5,"variant_options":[],"variants":[{"status_inventory":1,"status_order":5,"id":764082,"product_id":3567003,"sku":"SKU-3010975","barcode":"","quantity":10,"quantity_alert":0,"price":300000,"price_discount":0,"images":[],"display_order":0,"is_point":"","point":"","vat":"","weight":"","variant_options":[],"variant_option_name":"","image":"","price_final":300000,"price_final_format":"300.000 đ","price_format":"300.000 đ","price_discount_format":"0 đ","percent_discount":0,"date_sale":[],"percent_discount_format":"- 0%","price_discount_final_format":"300.000 đ"}],"variantIdDefault":764082,"image_list":[{"image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/gavix.jpg","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/\/thumb_images\/product\/gavix.jpg"}],"product_articles":[],"total_point_review":0,"link_youtube":"https:\/\/www.youtube.com\/embed\/","video_url":"","booking_url":"javascript:void(0)","file_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/gavix.jpg","config_panorama":[],"brand_name":"DHG Pharma","qr_code":"https:\/\/quaythuocyenphuong.biz.vn\/gavix-eng","promotion_name":"","status_inventory_value":1,"status_inventory":"Còn hàng","price":false,"price_final":"300.000 đ","percent_discount":false,"price_discount":false,"company_logo":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/your-logo.png","company_name":"(HỘ KINH DOANH) TRƯƠNG THỊ YẾN PHƯỢNG","company_email":"yenphuongyte@mail.com","company_phone":"","company_address":"","company_fax":"","date_now":1776433384,"company_tags":[],"search_keyword":null,"facebook_comment":"https:\/\/quaythuocyenphuong.biz.vn\/gavix","breadscrumb":[{"url":"https:\/\/quaythuocyenphuong.biz.vn","name":"Trang chủ","icon":"","active":false},{"url":"https:\/\/quaythuocyenphuong.biz.vn\/san-pham","name":"Sản phẩm","icon":"","active":false},{"url":"https:\/\/quaythuocyenphuong.biz.vn\/cardiovascular-diabetes","name":"Cardiovascular - Diabetes","icon":"","active":true}],"list_products_tmp":[],"list_section":[{"id":582419,"name":"SECTION-336","seo_name":"#w30s-section-582419","url":"#w30s-section-582419"},{"id":582420,"name":"SECTION-358","seo_name":"#w30s-section-582420","url":"#w30s-section-582420"},{"id":582448,"name":"SECTION-754","seo_name":"#w30s-section-582448","url":"#w30s-section-582448"},{"id":582449,"name":"SECTION-788","seo_name":"#w30s-section-582449","url":"#w30s-section-582449"},{"id":582450,"name":"SECTION-888","seo_name":"#w30s-section-582450","url":"#w30s-section-582450"},{"id":582451,"name":"SECTION-887","seo_name":"#w30s-section-582451","url":"#w30s-section-582451"},{"id":582421,"name":"SECTION-507","seo_name":"#w30s-section-582421","url":"#w30s-section-582421"},{"id":582422,"name":"SECTION-339","seo_name":"#w30s-section-582422","url":"#w30s-section-582422"}],"type_page":4,"id_page":399478,"widget_13902054":{"content_data":[{"id":72405,"title":"American","code":"us","is_expires":false,"is_active":0},{"id":72404,"title":"Tiếng Việt","code":"vn","is_expires":false,"is_active":1}]},"widget_13902056":{"content_data":{"content":""}},"widget_13902061":{"content_data":{"content":"Tài khoản"}},"widget_13902064":{"content_data":{"content":""}},"widget_13902057":{"content_data":[]},"widget_13902059":{"content_data":{"content":"Tìm kiếm"}},"widget_13902347":{"content_data":{"content":"<\/span>"}},"widget_13902335":{"content_data":{"price_final":"Contact"}},"widget_13902342":{"content_data":{"content":""}},"widget_13902330":{"content_data":{"content":"Product Code:"}},"widget_13902333":{"content_data":{"content":"Product Code:"}},"widget_13902343":{"content_data":{"content":""}},"widget_13902345":{"content_data":{"content":"add to cart&nbsp;"}},"widget_13902349":{"content_data":{"content":"<\/span>"}},"widget_13902363":{"content_data":{"content":"<\/span>"}},"widget_13902370":{"content_data":{"price_final":""}},"widget_13902364":{"content_data":{"content":"<\/span>"}},"widget_13902367":{"content_data":{"content":""}},"widget_13902359":{"content_data":[{"id":3567030,"name":"APITIM","desc":"Treatment of hypertension, especially in patients with metabolic complications such as diabetes.&nbsp;Treatment of chronic stable angina, coronary angina.<\/p>\n","content":"RECIPE:<\/strong><\/p>\n\nAmlodipine besilate, calculated according to Amlodipine .................................... 5mg<\/p>\n\nExcipients q.s ... ....................... 1 member<\/p>\n\n(Avicel, dicalci phosphate dihydrate, PVP K30, sodium lauryl sulfate, sodium starch glycolate, aerosil, magnesium stearate).<\/p>\n\nDOSAGE FORM:<\/strong> Hard capsule.<\/p>\n\nPRESENTATION:<\/strong> Box of 3 blisters x 10 tablets.<\/p>\n\nPHARMACOKINETICS:<\/strong> Apitim with active ingredient Amlodipine is a calcium antagonist belonging to dihydropyridine group. It inhibits the flow of calcium through the membrane into myocardial and smooth muscle cells of the vascular wall by blocking the slow calcium channels of the cell membrane. Thanks to the effect of the drug, the smooth muscle tone of the blood vessels decreases, thereby reducing the peripheral resistance leading to hypotension.<\/p>\n\nApitim fights angina mainly due to dilatation of peripheral arterioles and reduction of cardiac afterload. Myocardial energy consumption and oxygen demand decreased because the drug did not cause tachycardia reflex. Amlodipine dilates coronary arteries (arteries and arterioles) in both normal and anemic areas leading to increased oxygen supply to the heart muscle.<\/p>\n\nPHARMACOKINETICS:<\/strong> The bioavailability of Amlodipine when taken is about 60 - 80% and is not affected by food. The elimination half-life is 30-40 hours. Stable concentrations in plasma achieved 7-8 days after once a day medication. The volume of distribution is approximately 21 liters \/ kg body weight and the protein - plasma binding drug is high (over 98%). The drug is mainly metabolized by the liver. Inactive metabolites and excreted in the urine. In patients with hepatic impairment, reduce the dose or prolong the time between doses.<\/p>\n\nINDICATIONS:<\/strong> Treatment of hypertension, especially in patients with metabolic complications such as diabetes.<\/p>\n\nTreatment of chronic stable angina, coronary angina.<\/p>\n\nCONTRAINDICATIONS:<\/strong> Hypersensitivity to dihydropyridine derivatives. Not recommended for people with heart failure who have not been treated stably.<\/p>\n\nPRECAUTIONS:<\/strong> Impaired liver function, aortic stenosis, heart failure after acute myocardial infarction.<\/p>\n\nPREGNANT WOMEN AND LACTATION:<\/strong> Calcium channel blockers can inhibit early uterine contractions. However, the drug has no adverse effects during childbirth. The risk of hypoxia to the fetus should be taken into account if the mother lowers blood pressure. In experimental animals, calcium channel blockers can cause teratogenicity in the form of bone defects. Therefore, avoid Amlodipine for pregnant women, especially in the first 3 months of pregnancy.<\/p>\n\nThere have been no reports assessing the accumulation of Amlodipine in breast milk; Therefore, you should consult your doctor when using the drug during breastfeeding.<\/p>\n\nDRIVING AND OPERATION OF MACHINES:<\/strong> There are no documents on the effect of drugs on the ability to drive and operate machines. However, caution should be exercised because, like other hypertension medications, it can cause dizziness and dizziness.<\/p>\n\nINTERACTIONS:<\/strong> Anesthetics increase the effect of Amlodipine and may cause blood pressure to drop more sharply. Taking lithium with Amlodipine can cause neurotoxicity, nausea, vomiting, and diarrhea. Nonsteroidal anti-inflammatory drugs, especially indomethacin, may reduce the effect of Amlodipine. Use caution with drugs that are highly bound to plasma proteins (such as coumarin derivatives, hydantoin ...) with Amlodipine because Amlodipine is also highly protein bound, so the concentrations of these drugs in a free (unbound) form are may change in serum.<\/p>\n\nUNWANTED EFFECTS:<\/strong><\/p>\n\nCommon:<\/em> Ankle edema (dose related), headache, dizziness, flushing and feeling hot, tired, weak, palpitations, cramps, nausea, abdominal pain, indigestion , shortness of breath.<\/p>\n\nUncommon:<\/em> Excessive hypotension, tachycardia, chest pain, rash, itching, myalgia, arthralgia, sleep disorders.<\/p>\n\nRarely:<\/em> extrasystole, hyperplasia, hives, increased liver enzymes, hyperglycemia, confusion, erythema multiforme.<\/p>\n\nInform your doctor unwanted effects encountered when using the drug.<\/p>\n\nOVERDOSE AND TREATMENT:<\/strong> Amlodipine poisoning is very rare.<\/p>\n\nTreatment: Monitor the heart by using an electrocardiogram and symptomatic treatment of cardiovascular effects with gastric lavage and activated charcoal. If you need to adjust the electrolytes. In case of bradycardia and heart block, intravenous atropine must be injected, intravenous drip of calcium gluconate, isoprenalin or adrenalin or dopamine. For patients with reduced circulating volume, infusion of 0.9% sodium chloride solution is required. When a pacemaker is needed. In case of severe hypotension, intravenous injection of 0.9% sodium chloride solution, adrenalin. If this does not work, use isoprenalin in combination with amrinone.<\/p>\n\nDOSAGE AND ADMINISTRATION:<\/strong><\/p>\n\nDepending on the response of each patient.<\/p>\n\nInitial dose: Take 5 mg once daily, then increase gradually. May increase the dose to 10 mg once daily.<\/p>\n\nNo dose adjustment is required when combined with thiazide diuretics, beta-blockers or ACE inhibitors.<\/p>\n\nOr as directed by a physician.<\/p>\n\nRead the directions carefully before use.<\/p>\n\nExpiry date:<\/strong> 36 months from date of manufacture.<\/p>\n\nIf you need further information, please consult your doctor.<\/p>\n\nStorage conditions: Store in dry places, not exceeding 30o<\/sup>C, protect from light.<\/p>\n\nThis drug is for a doctor&#39;s prescription.<\/p>\n\nStandard:<\/strong> TCCS.<\/p>\n\nProduct packaging: 30<\/p>\n","image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/apitim.jpg?t=1600937043","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/product\/apitim.jpg?t=1601610200","tags":["apitim","hypertension","diabetes mellitus"],"count_view":685,"seo_name":"apitim-eng","date_update":"1744701790","date_created_format":"","meta_title":"","meta_desc":"","meta_keyword":"","sku":"SKU-3011000","code":"8935206007831","rate":0,"image_2_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/apitim.jpg?t=1600937043","image_2_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/product\/apitim.jpg?t=1601610200","time_promotion":false,"date_sale":[],"status_order":5,"variant_options":[],"variants":[{"status_inventory":1,"status_order":5,"id":764107,"product_id":3567030,"sku":"SKU-3011000","barcode":"","quantity":10,"quantity_alert":0,"price":100000,"price_discount":0,"images":[],"display_order":0,"is_point":"","point":"","vat":"","weight":"","variant_options":[],"variant_option_name":"","image":"","price_final":100000,"price_final_format":"100.000 đ","price_format":"100.000 đ","price_discount_format":"0 đ","percent_discount":0,"date_sale":[],"percent_discount_format":"- 0%","price_discount_final_format":"100.000 đ"}],"variantIdDefault":764107,"image_list":[{"image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/apitim.jpg","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/\/thumb_images\/product\/apitim.jpg"}],"product_articles":[],"total_point_review":0,"link_youtube":"https:\/\/www.youtube.com\/embed\/","video_url":"","booking_url":"javascript:void(0)","brand_name":"DHG Pharma","qr_code":"https:\/\/quaythuocyenphuong.biz.vn\/apitim-eng","promotion_name":"","status_inventory_value":1,"status_inventory":"Còn hàng","price":false,"price_final":"100.000 đ","percent_discount":false,"price_discount":false},{"id":3567006,"name":"ATORLIP 10","desc":"Atorlip is used in the following cases: increased total cholesterol, increased LDL-cholesterol, increased triglycerides.<\/p>\n","content":"RECIPE:<\/strong><\/p>\n\nAtorvastatin calcium ... ........... 10 mg<\/p>\n\nExcipients q.s ... ..................... 1 member<\/p>\n\n(Avicel, lactose, yellow tartrazine lake, sodium starch glycolate, PVP K30, magnesium stearate).<\/p>\n\nDOSAGE FORM:<\/strong> Tablets.<\/p>\n\nPRESENTATION:<\/strong> Box of 3 blisters x 10 tablets.<\/p>\n\nNATURE:<\/strong><\/p>\n\nAtorlip is a synthetic lipid-lowering drug, with the active ingredient is atorvastatin calcium, which inhibits the competitive competition of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, blocking HMG- CoA into mevalonat, a precursor of cholesterol. Atorvastatin reduces lipoprotein and plasma cholesterol by inhibiting the synthesis of cholesterol in the liver and by increasing the number of LDL (low density lipoprotein) receptors in the liver on the cell surface, thereby increasing its removal and degradation. LDL variable.<\/p>\n\nAtorvastatin reduces the most LDL cholesterol (25 - 61%) compared to any drug used alone, and proved to be promising for patients who need to reduce cholesterol a lot, which is currently only achieved when the drug combination. Atorvastatin raises the level of HDL (high density lipoprotein) cholesterol by 5 - 15% and thus lowers the ratio of LDL \/ HDL and total cholesterol \/ HDL. Atorvastatin also reduces plasma triglycerides by 10 - 30% by increasing clearance of VLDL (very low density lipoprotein) by LDL receptor.<\/p>\n\nIn clinical studies, the evidence suggests that statins significantly reduce coronary events, all cardiovascular events and reduce the total number of deaths in people with coronary artery disease.<\/p>\n\nAtorvastatin is rapidly absorbed after oral administration, the maximum concentration of drug in plasma is reached within 1-2 hours. The rate of absorption and atorvastatin concentration increases in proportion to the oral dose. Although food reduces the rate and extent of absorption of the drug, the therapeutic effect is unchanged when atorvastatin is taken orally with food. Atorvastatin plasma concentration after evening drug use is lower than in the morning. However, the effect is the same regardless of the time of day.<\/p>\n\nPOINT:<\/strong><\/p>\n\nAtorlip is used in the following cases: increased total cholesterol, increased LDL-cholesterol, increased triglycerides.<\/p>\n\nSlows the progression of coronary atherosclerosis.<\/p>\n\nPrimary prevention of coronary events in patients with hypercholesterolemia: reduces the risk of myocardial infarction, reduces the risk of coronary regeneration procedures, reduces the risk of death from cardiovascular disease.<\/p>\n\nCONTRAINDICATIONS:<\/strong><\/p>\n\nHypersensitivity to the drug.<\/p>\n\nActive liver disease, persistent elevation of serum transaminases and exceeding 3 times the upper limit of normal<\/p>\n\nPregnant or suspected pregnant women or nursing women.<\/p>\n\nCAREFUL:<\/strong><\/p>\n\nBefore starting statin therapy, it is necessary to identify the cause of hypercholesterolemia and quantify lipid indicators to determine the therapeutic dose. Lipid measurements should be performed periodically, at intervals not less than 4 weeks, and adjusted in accordance with the patient&#39;s response to the medication.<\/p>\n\nCaution should be used in patients who consume a lot of alcohol and \/ or have a history of liver disease. Liver function tests should be performed before starting treatment and during use.<\/p>\n\nStatin therapy has the potential to cause myositis and rhabdomyolysis, so the dose should be reduced or discontinued in patients with conditions suggestive of myositis (myalgia, muscle weakness, increased creatine phosphokinase by more than 10). times above the upper limit of normal) or there are risk factors for the development of secondary renal failure into paroxysmal myoglobulinuria.<\/p>\n\nDRUG INTERACTIONS:<\/strong><\/p>\n\nCombined treatment of atorvastatin with cyclosporin, gemfibrozil, erythromycin, itraconazole, ketoconazole, niacin increases the risk of myositis and rhabdomyolysis.<\/p>\n\nAtorvastatin enhances the effect of warfarin.<\/p>\n\nAntacids, cholestyramine reduce the concentration of atorvastatin in plasma.<\/p>\n\nUNWANTED EFFECTS:<\/strong><\/p>\n\nUsually mild and transient: constipation, flatulence, indigestion, abdominal pain, headache, nausea, muscle aches, fatigue, diarrhea, insomnia.<\/p>\n\nInform your doctor unwanted effects encountered when using the drug.<\/p>\n\nOVERDOSE AND TREATMENT:<\/strong><\/p>\n\nThere is no specific treatment when overdosing Atorvastatin. If overdose proceed to symptomatic treatment and necessary supportive measures. Due to the strong binding of plasma proteins, there is no hope to significantly increase Atorvastatin clearance by hemodialysis.<\/p>\n\nDOSAGE AND ADMINISTRATION:<\/strong><\/p>\n\nPatients should have a reasonable diet before treatment with Atorlip and should maintain this diet during treatment.<\/p>\n\nThe drug can be taken at any time of the day and does not depend on the meal.<\/p>\n\nInitial dose:<\/em> 10 - 20 mg once daily.<\/p>\n\nPatients who need to lower LDL-cholesterol (more than 45%) may start with a dose of 40 mg once daily.<\/p>\n\nTreatment dose:<\/em> 10 - 80 mg once daily, the dose is adjusted according to the results of testing of lipid index.<\/p>\n\nOr as directed by a physician.<\/p>\n\nRead the directions carefully before use.<\/p>\n\nIf you need further information, please consult your doctor.<\/p>\n\nThis drug is for a doctor&#39;s prescription.<\/p>\n\nExpiry date:<\/strong> 36 months from date of manufacture.<\/p>\n\nStorage conditions: Store in dry places, not exceeding 30o<\/sup>C.<\/p>\n\nStandard:<\/strong> TCCS.<\/p>\n\nProduct packaging:<\/strong> 30<\/p>\n","image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/atorlip-10.jpg?t=1600937042","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/product\/atorlip-10.jpg?t=1601610200","tags":["atorlip 10","cholesterol","atherosclerosis"],"count_view":560,"seo_name":"atorlip-10-eng","date_update":"1744701789","date_created_format":"","meta_title":"","meta_desc":"","meta_keyword":"","sku":"SKU-3010978","code":"8935206009002","rate":0,"image_2_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/atorlip-10.jpg?t=1600937042","image_2_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/product\/atorlip-10.jpg?t=1601610200","time_promotion":false,"date_sale":[],"status_order":5,"variant_options":[],"variants":[{"status_inventory":1,"status_order":5,"id":764085,"product_id":3567006,"sku":"SKU-3010978","barcode":"","quantity":10,"quantity_alert":0,"price":100000,"price_discount":0,"images":[],"display_order":0,"is_point":"","point":"","vat":"","weight":"","variant_options":[],"variant_option_name":"","image":"","price_final":100000,"price_final_format":"100.000 đ","price_format":"100.000 đ","price_discount_format":"0 đ","percent_discount":0,"date_sale":[],"percent_discount_format":"- 0%","price_discount_final_format":"100.000 đ"}],"variantIdDefault":764085,"image_list":[{"image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/atorlip-10.jpg","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/\/thumb_images\/product\/atorlip-10.jpg"}],"product_articles":[],"total_point_review":0,"link_youtube":"https:\/\/www.youtube.com\/embed\/","video_url":"","booking_url":"javascript:void(0)","brand_name":"DHG Pharma","qr_code":"https:\/\/quaythuocyenphuong.biz.vn\/atorlip-10-eng","promotion_name":"","status_inventory_value":1,"status_inventory":"Còn hàng","price":false,"price_final":"100.000 đ","percent_discount":false,"price_discount":false},{"id":3567005,"name":"ATORLIP 20","desc":"Atorlip is used in the following cases: increased total cholesterol, increased LDL-cholesterol, increased triglycerides.<\/p>\n","content":"RECIPE:<\/strong><\/p>\n\nAtorvastatin calcium ... .... ... 20 mg<\/p>\n\nExcipients q.s ... ................. 1 member<\/p>\n\n(Lactose, wheat starch, sodium starch glycolate, Kollidon VA 64, magnesium stearate).<\/p>\n\nDOSAGE FORM:<\/strong> Tablets.<\/p>\n\nPRESENTATION:<\/strong> Box of 3 blisters x 10 tablets.<\/p>\n\nPHARMACODYNAMICS:<\/strong> Atorlip is a synthetic lipid-lowering drug, with the active ingredient is Atorvastatin calcium, which inhibits the competitive effect of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, which prevents inhibits HMG-CoA&#39;s conversion to mevalonat, a precursor of cholesterol. Atorvastatin reduces lipoprotein and plasma cholesterol by inhibiting the synthesis of cholesterol in the liver and by increasing the number of LDL (low density lipoprotein) receptors in the liver on the cell surface, thereby increasing its removal and degradation. LDL variable.<\/p>\n\nAtorvastatin reduces the most LDL cholesterol (25 - 61%) compared to any drug used alone, and proved to be promising for patients who need to reduce cholesterol a lot, which is currently only achieved when the drug combination. Atorvastatin raises the level of HDL (high density lipoprotein) cholesterol by 5 - 15% and thereby lowers the ratio of LDL \/ HDL and total cholesterol \/ HDL. Atorvastatin also reduces plasma triglycerides by 10-30% by increasing clearance of VLDL (very low density lipoprotein) by LDL receptor.<\/p>\n\nIn clinical studies, the evidence suggests that statins significantly reduce coronary events, all cardiovascular events and reduce the total number of deaths in people with coronary artery disease.<\/p>\n\nPHARMACOKINETICS:<\/strong> Atorvastatin is rapidly absorbed after oral administration, the maximum concentration of drug in plasma is reached within 1-2 hours. The rate of absorption and concentration of Atorvastatin increases in proportion to the oral dose. Although food reduces the rate and extent of absorption of the drug, but the therapeutic effect is unchanged when Atorvastatin is taken orally with food. Atorvastatin plasma concentration after evening drug use is lower than in the morning. However, the effect is the same regardless of the time of day.<\/p>\n\nPOINT:<\/strong><\/p>\n\nAtorlip is used in the following cases: increased total cholesterol, increased LDL-cholesterol, increased triglycerides.<\/p>\n\nSlows the progression of coronary atherosclerosis.<\/p>\n\nPrimary prevention of coronary events in patients with hypercholesterolemia: reduces the risk of myocardial infarction, reduces the risk of coronary regeneration procedures, reduces the risk of death from cardiovascular disease.<\/p>\n\nCONTRAINDICATIONS:<\/strong> Hypersensitivity to the drug.<\/p>\n\nActive liver disease, persistent elevation of serum transaminases and exceeding 3 times the upper limit of normal<\/p>\n\nPregnant or suspected pregnant women or nursing women.<\/p>\n\nPRECAUTIONS:<\/strong> Before starting treatment with statins, it is necessary to identify the cause of hypercholesterolemia and quantify lipid indicators to determine the therapeutic dose. Lipid measurements should be performed periodically, at intervals not less than 4 weeks, and adjusted in accordance with the patient&#39;s response to the medication.<\/p>\n\nCaution should be used in patients who consume a lot of alcohol and \/ or have a history of liver disease. Liver function tests should be performed before starting treatment and during use.<\/p>\n\nStatin therapy has the potential to cause myositis and rhabdomyolysis, so the dose should be reduced or discontinued in patients with conditions suggestive of myositis (myalgia, muscle weakness, increased creatine phosphokinase by more than 10). times above the upper limit of normal) or there are risk factors for the development of secondary renal failure into paroxysmal myoglobulinuria.<\/p>\n\nINTERACTIONS:<\/strong> Combination treatment of Atorvastatin with cyclosporine, gemfibrozil, erythromycin, itraconazole, ketoconazole, niacin increases the risk of myositis and rhabdomyolysis.<\/p>\n\nAtorvastatin enhances the effect of warfarin.<\/p>\n\nAntacids, cholestyramine reduce the concentration of Atorvastatin in plasma.<\/p>\n\nUNWANTED EFFECTS:<\/strong><\/p>\n\nCommon:<\/em> Diarrhea, constipation, flatulence, abdominal pain, nausea, headache, dizziness, insomnia, weakness, myalgia.<\/p>\n\nUncommon:<\/em> Muscle weakness, rash, rhinitis, sinusitis, sore throat.<\/p>\n\nRarely:<\/em> Myositis, rhabdomyolysis, resulting in secondary renal failure due to myoglobinuria.<\/p>\n\nInform your doctor unwanted effects encountered when using the drug.<\/p>\n\nOVERDOSE AND TREATMENT:<\/strong> There is no specific treatment when using Atorvastatin overdose. If overdose proceed to symptomatic treatment and necessary supportive measures. Due to the strong binding of plasma proteins, there is no hope to significantly increase Atorvastatin clearance by hemodialysis.<\/p>\n\nHOW TO USE:<\/strong><\/p>\n\nPatients should have a reasonable diet before treatment with Atorlip and should maintain this diet during treatment.<\/p>\n\nThe drug can be taken at any time of the day and does not depend on the meal.<\/p>\n\nInitial dose:<\/em> 10 - 20 mg once daily.<\/p>\n\nPatients who need to lower LDL-cholesterol (more than 45%) may start with a dose of 40 mg once daily.<\/p>\n\nTreatment dose:<\/em> 10 - 80 mg once daily, the dose is adjusted according to the results of testing of lipid index.<\/p>\n\nOr as directed by a physician.<\/p>\n\nRead the directions carefully before use.<\/p>\n\nIf you need further information, please consult your doctor.<\/p>\n\nExpiry date:<\/strong> 36 months from date of manufacture.<\/p>\n","image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/atorlip-20.jpg?t=1600937042","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/product\/atorlip-20.jpg?t=1601610200","tags":["atorlip 20","cholesterol","coronary atherosclerosis"],"count_view":399,"seo_name":"atorlip-20-eng","date_update":"1744701789","date_created_format":"","meta_title":"","meta_desc":"","meta_keyword":"","sku":"SKU-3010977","code":"8935206099996","rate":0,"image_2_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/atorlip-20.jpg?t=1600937042","image_2_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/product\/atorlip-20.jpg?t=1601610200","time_promotion":false,"date_sale":[],"status_order":5,"variant_options":[],"variants":[{"status_inventory":1,"status_order":5,"id":764084,"product_id":3567005,"sku":"SKU-3010977","barcode":"","quantity":10,"quantity_alert":0,"price":100000,"price_discount":0,"images":[],"display_order":0,"is_point":"","point":"","vat":"","weight":"","variant_options":[],"variant_option_name":"","image":"","price_final":100000,"price_final_format":"100.000 đ","price_format":"100.000 đ","price_discount_format":"0 đ","percent_discount":0,"date_sale":[],"percent_discount_format":"- 0%","price_discount_final_format":"100.000 đ"}],"variantIdDefault":764084,"image_list":[{"image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/atorlip-20.jpg","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/\/thumb_images\/product\/atorlip-20.jpg"}],"product_articles":[],"total_point_review":0,"link_youtube":"https:\/\/www.youtube.com\/embed\/","video_url":"","booking_url":"javascript:void(0)","brand_name":"DHG Pharma","qr_code":"https:\/\/quaythuocyenphuong.biz.vn\/atorlip-20-eng","promotion_name":"","status_inventory_value":1,"status_inventory":"Còn hàng","price":false,"price_final":"100.000 đ","percent_discount":false,"price_discount":false},{"id":3567004,"name":"GLIRITDHG 500\/2.5","desc":"Treatment of type 2 diabetes is aimed at controlling blood sugar levels, combined with diet and exercise.<\/p>\n","content":"RECIPE:<\/strong><\/p>\n\nMetformin HCl ................................................ .................. 500 mg<\/p>\n\nGlibenclamid ... .................................... 2.5 mg<\/p>\n\nExcipients q.s ... .............................................. 1 member<\/p>\n\n(Avicel, lactose, PVP K30, croscarmellose sodium, magnesium stearate, HPMC, PVA, PEG 6000, titanium dioxide, talc, yellow iron oxide color, red iron oxide color).<\/p>\n\nDOSAGE FORM:<\/strong> Film-coated tablets.<\/p>\n\nPRESENTATION:<\/strong> Box of 3 blisters x 10 tablets.<\/p>\n\nPHARMACODYNAMICS:<\/strong> GliritDHG 500mg \/ 2.5mg is a drug to treat type 2 diabetes, with the main active ingredient is metformin combined with glibenclamide. Metformin belongs to the biguanid group, whose mechanism of peripheral action is to increase the use of glucose in cells, improve the association of insulin with receptors, inhibit glucose synthesis in the liver and reduce intestinal absorption of glucose. Metformin has no hypoglycemic effect in people without diabetes. In people with diabetes, metformin reduces hyperglycemia but does not cause catastrophic hypoglycemic events unless fasting or a synergistic combination. Glibenclamide is a sulfonylurea that reduces blood glucose levels, mainly by stimulating pancreatic beta cells to increase endogenous insulin secretion. During short-term treatment, the blood glucose level decreases because the drug reduces the glucose flow of the liver into the blood and increases the insulin effect on peripheral target cells. With long-term use of glibenclamide, blood insulin levels drop to the levels they were before treatment, but glucose tolerance continues to improve. Although the mechanisms of action of metformin and glibenclamide are different, they complement one another and may have synergistic effects on glycemic control when monotherapy does not control blood sugar as required.<\/p>\n\nPHARMACOKINETICS:<\/strong> Metformin is slowly and incompletely absorbed from the gastrointestinal tract. The absolute bioavailability of 500 mg metformin orally on fasting is approximately 50 - 60%. There is no proportion to the dose when increasing the dose, due to reduced absorption. Food reduces the rate of absorption and slows down the absorption of metformin. Metformin is not metabolized in the liver and is not excreted in the bile. Metformin is excreted by the kidneys as a non-metabolized form. The plasma half-life is 1.5 - 4.5 hours.<\/p>\n\nGlibenclamide is well absorbed from the gastrointestinal tract. Food does not affect the rate and extent of absorption of the drug. Duration of effect is 45 - 60 minutes and reaches a maximum within 1.5 - 3 hours. The volume of distribution of glibenclamide is about 0.125 liters \/ kg, the average elimination half-life is 1.4 - 1.8 hours, and may be prolonged in patients with hepatic or renal impairment. It is usually possible to take the medication only once a day. Glibenclamide is completely metabolized in the liver to active metabolites and excreted in urine and feces.<\/p>\n\nINDICATIONS:<\/strong> Treatment of type 2 diabetes mellitus to control blood sugar, combined with diet and exercise.<\/p>\n\nCONTRAINDICATIONS:<\/strong> Patients with a history of hypersensitivity to metformin, glibenclamide, sulfonamides, diuretics with active ingredient sulfonamide or probenecid or any of its ingredients.<\/p>\n\nInsulin-dependent diabetes mellitus (type 1 diabetes). Type 2 diabetes mellitus for people under 18. Complicated diabetes mellitus. Diabetes when stressed.<\/p>\n\nPatients with acute catabolic state, severe infection, sepsis, trauma, severe respiratory disease with hypoxemia, hyperglycemia with or without coma, severe acidosis due to hyperglycemia, impairment congestive heart, cardiovascular collapse, acute myocardial infarction.<\/p>\n\nSevere liver or kidney damage, severe malnutrition. Exacerbations of chronic disease.<\/p>\n\nPatients with severe renal impairment (eGFR less than 30 mL \/ minute \/ 1.73 m2) [see Warnings and precautions].<\/p>\n\nPatients with acute or chronic metabolic acidosis, including diabetic ketoacidosis.<\/p>\n\nPRECAUTIONS:<\/strong> Adherence to the diet and medication are crucial for successful treatment and to prevent undesirable changes in blood glucose levels.<\/p>\n\nHypoglycemia is more likely to occur when you eat less, exercise excessively, prolong, or when drinking alcohol, or when used in combination with another blood glucose lowering medication.<\/p>\n\nUndernourished, hardened brain arteries.<\/p>\n\nLactic acidosis<\/p>\n\nAfter-sales surveillance has documented metformin-associated lactic acidosis, including fatalities, hypothermia, hypotension, persistent bradycardia. The onset of metformin-associated lactic acidosis is usually not easily detected, accompanied by atypical symptoms such as malaise, myalgia, respiratory failure, drowsiness and abdominal pain. Lactic acidosis associated with metformin is characterized by increased lactate concentration in the blood (&gt; 5 mmol \/ L), anion gap (without evidence of urinary or diabetic ketoacidosis), an increase in the lactate \/ pyruvate ratio and plasma metformin levels generally increase&gt; 5&micro;g \/ mL.<\/p>\n\nMeasures to minimize the risk and management of metformin acid lactic acidosis in high-risk patients are detailed in the drug use leaflet (Dosage and administration, Contraindications, Warnings and precautions, Drug Interactions and Drug Use on special subjects).<\/p>\n\nIf lactic acidosis is suspected of being related to metformin, stop using metformin, promptly take the patient to hospital and take preventive measures. In patients who have been treated with metformin, have been diagnosed with lactic acidosis or are suspected of having a high likelihood of lactic acidosis, it is recommended that fast dialysis be used to correct the acidosis situation and to remove the accumulated metformin ( metformin hydrochloride can be dialysed with a clearance of 170 mL \/ min under good hemodynamic conditions). Dialysis can reverse symptoms and recover.<\/p>\n\nEducate patients and family members about the symptoms of lactic acidosis and if these symptoms occur, discontinue the medication and report these symptoms to the doctor.<\/p>\n\nFor each factor that increases the risk of metformin-associated lactic acidosis, recommendations are made to minimize the risk and manage the metformin-associated lactic acidosis, specifically as follows:<\/p>\n\nRenal impairment: Lactic acidosis associated with metformin during after-sales drug monitoring occurs primarily in patients with severe renal impairment. The risk of metformin accumulation and lactic acidosis associated with metformin increases with the severity of renal failure because metformin is eliminated mainly by the kidneys. Clinical recommendations based on the patient&#39;s renal function include [see Dosage and administration, Clinical pharmacology]:<\/p>\n\n- Before starting treatment with metformin it is necessary to estimate the patient&#39;s glomerular filtration rate (eGFR).<\/p>\n\n- Metformin contraindicated in patients with eGFR below 30 mL \/ minute \/ 1.73 m2 [see section Contraindications].<\/p>\n\n- It is not recommended to start treatment with metformin in patients with eGFR ranging from 30-45 mL \/ min \/ 1.73 m2.<\/p>\n\n- Collect data on eGFR at least once a year in all patients using metformin, in patients with an increased risk of renal failure (e.g., elderly), renal function should be assessed. more often.<\/p>\n\n- In patients on metformin and with an eGFR of less than 45 mL \/ min \/ 1.73 m2, assess the risks and benefits of continuing the regimen.<\/p>\n\nDrug interactions:<\/em> Concomitant use of metformin with certain medications may increase the risk of metformin-associated lactic acidosis: patients with impaired renal function lead to significant hemodynamic changes, affecting weight. by acid-base or by increasing metformin accumulation [see Drug Interactions section]. Therefore, consider monitoring patients more often.<\/p>\n\nPatients aged 65 years and older:<\/em> The risk of metformin-associated lactic acidosis increases with the age of the patient because elderly patients are more likely to have liver, kidney, and heart failure than younger patients. Renal function should be assessed more frequently in elderly patients.<\/p>\n\nPerform diagnostic tests using contrast medicine:<\/em> Intravascular injection in patients receiving metformin may lead to acute impairment of renal function and cause lactic acidosis. Stop metformin before or at the time of the scan using iodine-containing contrast media in patients with eGFR of 30-60 mL \/ min \/ 1.73 m2, patients with a history of impairment liver, alcoholism, heart failure or patients will use contrast dye containing iodine by the artery. Re-evaluate eGFR 48 hours after the scan and use metformin again if kidney function is stable.<\/p>\n\nSurgery or other procedures:<\/em> Storing food and fluids during surgery or performing other procedures may increase the risk of volume reduction, hypotension and kidney failure. Metformin should be temporarily discontinued when the patient has a restricted food or fluid intake.<\/p>\n\nInhaled hypoxia:<\/em> Afterschool monitoring has documented a number of metformin-associated lactic acidosis occurring in acute congestive heart failure (especially when accompanied by reduced perfusion and hypoxemia. ). Cardiovascular insufficiency (shock), acute myocardial infarction, sepsis and other conditions associated with hypoxia are associated with lactic acidosis and may also cause pre-renal blood nitrogen. When these events occur, stop metformin.<\/p>\n\nAlcohol consumption:<\/em> Alcohol may affect the effect of metformin on lactate metabolism and may thereby increase the risk of metformin-associated lactic acidosis. Warn patients not to drink alcohol while using metformin.<\/p>\n\nHepatic Impairment:<\/em> Patients with hepatic impairment may develop metformin acid-related lactic acidosis due to impaired lactate elimination leading to increased lactate levels in the blood. Therefore, metformin should be avoided in patients who have been diagnosed with liver disease through clinical or laboratory evidence.<\/p>\n\nPREGNANT WOMEN AND LACTATION:<\/strong> The drug is contraindicated on these subjects.<\/p>\n\nThe development of lactic acidosis is related to metformin due to a decrease in lactate elimination leading to an increase in lactate levels in the blood. Therefore, metformin should be avoided in patients who have been diagnosed with liver disease through clinical or laboratory evidence.<\/p>\n\nPREGNANT WOMEN AND LACTATION:<\/strong> The drug is contraindicated on these subjects.<\/p>\n\nDRIVING AND OPERATING MACHINERY:<\/strong> Be cautious when driving and operating machinery because of the risk of hypoglycemia.<\/p>\n\nINTERACTIONS:<\/strong> Glirit hypoglycemic effect of GliritDHG 500mg \/ 2.5mg may be increased in combination with sulfonamides, salicylates, phenylbutazone, nonsteroidal anti-inflammatory drugs, fluoroquinolones, cumarin derivatives, beta blockers, monoaminoxydase inhibitors, perhexilin, chloramphenicol, clofibrate and fenofibrate, sulfinpyrazone, probenecid, pentoxifylin, cyclophosphamid, azapropazon, tetracyclin, angiotensin converting enzyme, alcohol, fluconazol, miconazol, eniproflolo<\/p>\n\nThe hypoglycemic effect of GliritDHG 500mg \/ 2.5mg may be reduced when combined with thiazide diuretics, ethacrynic acid, oral contraceptives containing estrogen \/ gestagen, phenothiazine derivatives, isoniazid, nicotinic acid (high dose). ), sympathomimetics, thyroid preparations and corticosteroids, salbutamol or terbutalin (intravenously).<\/p>\n\nIncreased toxicity when combined with: cationic (amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim and vancomycin), cimetidine.<\/p>\n\nUNWANTED EFFECTS:<\/strong><\/p>\n\nUsually dose-related and usually occur at the beginning of treatment:<\/p>\n\nCommon:<\/em> anorexia, nausea, vomiting, diarrhea, epigastric, constipation, heartburn; ban, urticaria, sensuality with light.<\/p>\n\nUncommon:<\/em> dysplasia of blood, aplastic anemia, hemolytic anemia, myelosuppression, thrombocytopenia, agranulocytosis, lactic acidosis.<\/p>\n\nRarely:<\/em> Temporary vision loss.<\/p>\n\nInform your doctor unwanted effects encountered when using the drug.<\/p>\n\nOVERDOSE AND TREATMENT:<\/strong> Hypoglycemic reactions may occur due to an overdose, an interaction with certain medications or a mistake in eating. Manifestations: headache, irritation, restlessness, excessive sweating, insomnia, tremor, behavioral disorders, less alertness, agility.<\/p>\n\nRemedy by eating sugar (about 20 - 30 g) and immediately notify the doctor. If the patient is in a coma, either saccharose or glucose solution can be injected into the stomach or infused glucose into a vein.<\/p>\n\nDOSAGE AND ADMINISTRATION:<\/strong> Take the drug about 30 minutes before a meal.<\/p>\n\nThe recommended dose of Metformin<\/p>\n\nThe starting dose for patients not taking metformin is 500 mg, once daily, orally. If the patient does not experience adverse gastrointestinal reactions and needs to increase the dose, an additional 500 mg may be administered at intervals of 1 to 2 weeks. Dosage of metformin should be considered adjusted on a patient-by-patient basis based on patient efficacy and tolerance and does not exceed the maximum recommended dose of 2000 mg \/ day.<\/p>\n\nDosage of GliritDHG<\/p>\n\nInitial dosage:<\/em> usually take 1 tablet of GliritDHG 500mg \/ 2.5mg 30 minutes before breakfast. If you need to adjust the dose, after 2 weeks, increase to 1 tablet of GliritDHG 500mg \/ 5mg<\/p>\n\nMaximum dose:<\/em> 2000 mg \/ 20 mg \/ day (4 tablets GliritDHG 500mg \/ 5mg \/ day). Drink before meals.<\/p>\n\nEach dose should be explored individually to avoid hypoglycemia.<\/p>\n\nPatients must follow the diet according to the instructions of the treating doctor.<\/p>\n\nRecommended use of the drug in patients with renal insufficiency<\/p>\n\nAssess renal function before initiating treatment with metformin and evaluate periodically thereafter.<\/p>\n\nMetformin is contraindicated in patients with eGFR below 30 mL \/ minute \/ 1.73 m2<\/p>\n\nTreatment with metformin is not recommended in patients with eGFR ranging from 30-45 mL \/ min \/ 1.73 m2.<\/p>\n\nIn patients who are on metformin and have an eGFR of less than 45 mL \/ min \/ 1.73 m2, assess the risk - benefit of continued treatment.<\/p>\n\nStop using metformin if the patient has an eGFR that falls below 30 mL \/ minute \/ 1.73 m2 [see Contraindications, Warnings and Precautions section].<\/p>\n\nStop using metformin when doing imaging tests using iodine-containing contrast media<\/p>\n\nIn patients with an annual eGFR of 30 - 60 mL \/ minute \/ 1.73 m2, in patients with a history of liver disease, alcoholism or heart failure, or in patients who will receive contrast drugs photodiodes contain iodine via arteries, stop metformin before or at the time of carrying out diagnostic imaging tests using iodine-containing contrast media. Re-evaluate the eGFR after 48 hours of metformin scan if the kidney function is stable [see Warnings and precautions].<\/p>\n\nOr as directed by a physician.<\/p>\n\nRead the directions carefully before use.<\/p>\n\nIf you need further information, please consult your doctor.<\/p>\n\nThis drug is for a doctor&#39;s prescription.<\/p>\n\nExpiry date:<\/strong> 36 months from date of manufacture.<\/p>\n\nStorage conditions:<\/strong> Store in dry places, not exceeding 30o<\/sup>C, protect from light.<\/p>\n\nStandard:<\/strong> TCCS....<\/p>\n","image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/gliritdhg-500-2-5.jpg?t=1600937042","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/product\/gliritdhg-500-2-5.jpg?t=1601610198","tags":["gliritdhg","type 2 diabetes mellitus","diabetes mellitus"],"count_view":527,"seo_name":"gliritdhg-500-2-5-eng","date_update":"1744701789","date_created_format":"","meta_title":"","meta_desc":"","meta_keyword":"","sku":"SKU-3010976","code":"8935206099997","rate":0,"image_2_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/gliritdhg-500-2-5.jpg?t=1600937042","image_2_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/product\/gliritdhg-500-2-5.jpg?t=1601610198","time_promotion":false,"date_sale":[],"status_order":5,"variant_options":[],"variants":[{"status_inventory":1,"status_order":5,"id":764083,"product_id":3567004,"sku":"SKU-3010976","barcode":"","quantity":10,"quantity_alert":0,"price":100000,"price_discount":0,"images":[],"display_order":0,"is_point":"","point":"","vat":"","weight":"","variant_options":[],"variant_option_name":"","image":"","price_final":100000,"price_final_format":"100.000 đ","price_format":"100.000 đ","price_discount_format":"0 đ","percent_discount":0,"date_sale":[],"percent_discount_format":"- 0%","price_discount_final_format":"100.000 đ"}],"variantIdDefault":764083,"image_list":[{"image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/gliritdhg-500-2-5.jpg","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/\/thumb_images\/product\/gliritdhg-500-2-5.jpg"}],"product_articles":[],"total_point_review":0,"link_youtube":"https:\/\/www.youtube.com\/embed\/","video_url":"","booking_url":"javascript:void(0)","brand_name":"DHG Pharma","qr_code":"https:\/\/quaythuocyenphuong.biz.vn\/gliritdhg-500-2-5-eng","promotion_name":"","status_inventory_value":1,"status_inventory":"Còn hàng","price":false,"price_final":"100.000 đ","percent_discount":false,"price_discount":false},{"id":3567029,"name":"COPERIL PLUS","desc":"Primary hypertension for uncontrolled blood pressure subjects with monotherapy.<\/p>\n","content":"RECIPE:<\/strong><\/p>\n\nPerindopril erbumin .................................. 4 mg<\/p>\n\nIndapamid ........................... 1.25 mg<\/p>\n\nExcipients 1 capsule<\/p>\n\n(Lactose, avicel, PVP K30, sodium starch glycolate, magnesium stearate).<\/p>\n\nDOSAGE FORM:<\/strong> Tablets.<\/p>\n\nPRESENTATION:<\/strong> Box of 1 blister x 30 tablets.<\/p>\n\nPHARMACODYNAMIC:<\/strong><\/p>\n\nPerindopril is an angiotensin converting enzyme inhibitor (ACE: Angiotensin Converting Enzyme), acting through the activity of perindoprilat metabolite. Perindopril prevents angiotensin I from converting into angiotensin II, a potent vasoconstrictor. ACE inhibitors reduce angiotensin II in plasma, leading to increased renin activity in plasma and lead to decreased secretion of aldosteron, so reduce sodium retention and increase potassium retention in the body. Because ACE inactivates bradykinin, ACE inhibition also leads to increased activity of the local Kallikrein-Kinin system in the circulation and thus activates the prostaglandin system, which also contributes to lower blood pressure. In hypertension, perindopril reduces blood pressure by reducing systemic peripheral resistance. The drug usually causes varicose veins and possibly veins.<\/p>\n\nIndapamide is a diuretic sulfonamide. Indapamide has a diuretic and anti-hypertensive effect. The drug inhibits the reabsorption of sodium ions in the diluted section of the distal tubule, increases sodium and chloride secretion, thereby increasing diuresis. Indapamide causes the vessel&#39;s response to vasoconstrictor amines to return to normal, reducing peripheral small artery resistance. The drug maintains its antihypertensive effect in patients with no renal function.<\/p>\n\nPHARMACOKINETICS:<\/strong> The drug is rapidly absorbed after oral administration. The drug is strongly metabolized, mainly in the liver. Perindopril is converted into active perindoprilat, food reduces the biotransformation into perindoprilat and thereby reduces bioavailability. The drug is eliminated mainly through urine. Hemodialysis does not remove indapamide from the circulation.<\/p>\n\nINDICATIONS:<\/strong> Primary hypertension for subjects with uncontrolled blood pressure with monotherapy.<\/p>\n\nCONTRAINDICATIONS:<\/strong><\/p>\n\nHypersensitivity to perindopril, indapamide and sulfonamide derivatives.<\/p>\n\nPeople with a history of angioedema have been linked to ACE inhibitors. New patients with stroke, anuria. Patients with severe renal impairment (creatinine clearance &lt;30 ml \/ min)<\/p>\n\nBecause there are no studies in children, it is currently contraindicated for children.<\/p>\n\nPRECAUTIONS:<\/strong> Regarding perindopril: Caution should be exercised when administering the drug to patients with the following risks: In case of heart failure, dehydration, risk of hypotension and \/ or renal failure, renal artery stenosis. Hemodialysis patients, renal insufficiency, renal vascular hypertension, congestive heart failure, patients undergoing surgery, diabetes, stable angina. Elderly.<\/p>\n\nRelated to indapamide: Caution should be used in patients with severe renal disease, patients with impaired liver function or progressive liver disease, patients with hyperparathyroidism or thyroid conditions, patients with surgery Cut off sympathetic nerves. Periodically determine blood glucose levels, especially in patients who have or suspected diabetes.<\/p>\n\nPREGNANT WOMEN AND LACTATION:<\/strong><\/p>\n\nDo not use the drug for pregnant and lactating women.<\/p>\n\nDRIVING AND OPERATING MACHINERY:<\/strong><\/p>\n\nUse with caution because the drug can cause headaches, dizziness.<\/p>\n\nDRUG INTERACTIONS:<\/strong><\/p>\n\nNonsteroidal anti-inflammatory drugs, corticosteroids, tetracosactide reduce the effect of perindopril. The antihypertensive effect of perindopril may become excessive when a previous diuretic is used. Combination with sedatives and antidepressants imipramine will increase the risk of orthostatic hypotension. Perindopril increases the hypoglycemic effect of insulin and oral hypoglycemic agents. Combining perindopril with diuretics to keep potassium and potassium salts at risk of hyperkalemia, especially in renal failure. The combination of lithium and perindopril increases blood lithium.<\/p>\n\nDo not combine Indapamide with other diuretics because it can cause hypokalemia and hyperuricemia. Do not use with lithium because of the risk of lithium toxicity. Indapamide reduces the arterial response to vasoconstrictors such as noradrenalin, but not enough to prevent noradrenalin.<\/p>\n\nUNWANTED EFFECTS:<\/strong><\/p>\n\nPerindopril-related:<\/em> headache, mood disorders and \/ or sleep, weakness; taste disorders, dizziness, cramps; skin rash; dry cough type of irritation; impotence, dry mouth; slightly reduced hemoglobin; hyperkalemia; angioedema of the face, extremities, lips, tongue, glottis and \/ or larynx.<\/p>\n\nAssociated with indapamide:<\/em> fluid electrolyte disturbance, hypokalemia, hyponatremia or alkalosis due to hypochloremia; fatigue, muscle weakness; headache, dizziness, dizziness; loss of appetite, nausea, vomiting; Orthostatic hypotension, palpitations; rash, rashes, urticaria; thrombocytopenia, agranulocytosis; acute myopia, cramps.<\/p>\n\nInform your doctor unwanted effects encountered when using the drug.<\/p>\n\nOVERDOSE AND TREATMENT:<\/strong><\/p>\n\nRelated to indapamide:<\/em> Symptoms: Electrolyte disorders, hypotension, muscle weakness, digestive disorders, nausea, vomiting, respiratory failure. Treatment of overdose is symptomatic treatment, there is no specific antidote. If acute overdose, conduct gastric lavage or induce vomiting, carefully assess water and electrolytes afterwards. Treatment support maintenance of respiratory and circulatory function.<\/p>\n\nRelated to perindopril:<\/em> Symptoms associated with hypotension. Treatment: Wash the stomach and establish an intravenous line immediately to give isotonic saline solution. Conducting dialysis (70 ml \/ min) can remove perindopril from the blood.<\/p>\n\nDOSAGE AND ADMINISTRATION:<\/strong> Coperil Plus is usually given once in the morning, before meals.<\/p>\n\nDose in hypertension:<\/em> 1 Coperil Plus tablet daily (perindopril 4 mg \/ indapamid 1.25 mg).<\/p>\n\nRenal impairment:<\/em> Creatinine clearance&gt; 60 ml \/ min: No dose adjustment is necessary; creatinine clearance from 30 to 60 ml \/ min: Start with a dose corresponding to each component of the combination form that the patient tolerates (the recommended dose perindopril is 2 mg \/ day), it is not recommended to split tablets. Coperil Plus drug, so should find another suitable dosage form.<\/p>\n\nFor elderly patients:<\/em> The starting dose needs to be adjusted depending on the response of blood pressure, especially when there is a loss of salt and water, to avoid the sudden onset of hypotension.<\/p>\n\nOr as directed by a physician.<\/p>\n\nRead the directions carefully before use.<\/p>\n\nIf you need further information, please consult your doctor.<\/p>\n\nThis drug is for a doctor&#39;s prescription.<\/p>\n\nExpiry date:<\/strong> 36 months from date of manufacture.<\/p>\n\nStorage conditions:<\/strong> Store in dry places, not exceeding 30o<\/sup>C, protect from light.<\/p>\n\nStandard:<\/strong> TCCS.<\/p>\n","image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/coperil-plus.jpg?t=1600937043","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/product\/coperil-plus.jpg?t=1601610198","tags":["coperil plus","hypertension","blood pressure"],"count_view":958,"seo_name":"coperil-plus-eng","date_update":"1744701790","date_created_format":"","meta_title":"","meta_desc":"","meta_keyword":"","sku":"SKU-3010999","code":"8935206099998","rate":0,"image_2_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/coperil-plus.jpg?t=1600937043","image_2_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/product\/coperil-plus.jpg?t=1601610198","time_promotion":false,"date_sale":[],"status_order":5,"variant_options":[],"variants":[{"status_inventory":1,"status_order":5,"id":764106,"product_id":3567029,"sku":"SKU-3010999","barcode":"","quantity":10,"quantity_alert":0,"price":300000,"price_discount":0,"images":[],"display_order":0,"is_point":"","point":"","vat":"","weight":"","variant_options":[],"variant_option_name":"","image":"","price_final":300000,"price_final_format":"300.000 đ","price_format":"300.000 đ","price_discount_format":"0 đ","percent_discount":0,"date_sale":[],"percent_discount_format":"- 0%","price_discount_final_format":"300.000 đ"}],"variantIdDefault":764106,"image_list":[{"image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/product\/coperil-plus.jpg","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/\/thumb_images\/product\/coperil-plus.jpg"}],"product_articles":[],"total_point_review":0,"link_youtube":"https:\/\/www.youtube.com\/embed\/","video_url":"","booking_url":"javascript:void(0)","brand_name":"DHG Pharma","qr_code":"https:\/\/quaythuocyenphuong.biz.vn\/coperil-plus-eng","promotion_name":"","status_inventory_value":1,"status_inventory":"Còn hàng","price":false,"price_final":"300.000 đ","percent_discount":false,"price_discount":false}]},"widget_13902365":{"content_data":{"content":"<\/span>"}},"widget_13902366":{"content_data":{"content":"<\/span><\/span>"}},"widget_13902358":{"content_data":{"content":"RELATED PRODUCTS<\/span>"}},"widget_13902069":{"content_data":{"content":"ABOUt us<\/span>"}},"widget_13902070":{"content_data":{"content":"Address: 196 Nguyen Dinh Chieu St.&nbsp;, Ward&nbsp;6, District&nbsp;3, Ho Chi Minh City, Vietnam<\/p>\n\nHotline: 1900 9477<\/p>\n\nEmail: info@demo8017.web30s.vn<\/p>\n"}},"widget_13902074":{"content_data":{"content":"services<\/span><\/span><\/span>"}},"widget_13902075":{"content_data":[{"id":63281,"name":"Periodic dental examinations","desc":"Periodic dental care is essential in preventing dental diseases and helps in the early detection of dental diseases.<\/p>\n","content":"Periodic dental care is essential in preventing dental diseases and helps in the early detection of dental diseases.<\/strong><\/p>\n\nA beautiful smile, with strong teeth, fresh breath is very important for every person in everyday life. Schedule a period of regular dental check-ups at least every 6 months. That&#39;s what dentists recommend to everyone to note and create good habits in dental care.<\/p>\n\n<img alt=\"Periodic dental examinations\" src=\"\/datafiles\/30048\/upload\/images\/service\/kham-rang-dinh-ky.jpg\" \/><\/p>\n\nScraping lime polishing teeth<\/strong><\/p>\n\nAfter every 6 months the teeth need to be cleaned, remove plaque from the roots and polish the teeth.<\/p>\n\nFood, saliva and bacteria accumulate to form plaque on the surface of teeth. Some time later, the plaque hardens into tartar, which causes gingivitis and, if left untreated, will lead to periodontitis, resulting in loose teeth.<\/p>\n\nHealthy gums are pale pink, firm. When inflamed, swollen red gums are prone to bleeding. Scrape and polish teeth is essential to prevent inflammation and damage of the gums \/ gums. Scraping can be done manually, mechanically or in combination.<\/p>\n\nThe process of scrapping of tartar is done basically as follows: Teeth are scraped clean to remove plaque and lime on the teeth, followed by the tartar that is deep under the gums is also cleaned and smooth. Dental scraper uses ultrasonic waves to remove dental plaque that adheres to the surface of the teeth, so it does not damage the gums nor wear enamel.<\/p>\n\nScrape tartar is an effective way to minimize bleeding of the teeth, swollen gums, reduce gums, reduce the discomfort caused by gingivitis, prevent tooth loss and bone resorption, resulting in a confident smile.<\/p>\n\nFinally a polishing brush and polishing agent are used to polish the inside and outside of the teeth. The purpose of polishing the tooth surface is to smooth the tooth surface and help prevent plaque buildup on the teeth.<\/p>\n\nAt the clinic we use NSK sand blower system for cleaning services. After the teeth are shaved and polished, the doctor will sand your teeth clean each interdental and remove any plaque.<\/p>\n\nGeneral examination of dental condition<\/strong><\/p>\n\nYou should have regular dental checkups 2-3 times \/ year. Through examination, the doctor will detect to help you have decayed teeth, gum disease (gingivitis, periodontitis, fungal infection, cancer lesions ...) or other abnormalities (coral, pinched teeth , crowded teeth, lack of teething space, lack of tooth germ, deviant teeth ....), from which there will be timely treatment measures.<\/p>\n\nEarly treatment is always more effective and less expensive.<\/p>\n\nOn a thorough physical exam, periodontal (the entire area around the tooth) and structures of the mouth; In addition to the direct examination of the dentist for the condition of the teeth, periodontal imaging is necessary to fully and accurately assess the status of the jawbone and the internal structures.<\/p>\n\nAt the clinic, we are equipped with the world&#39;s most advanced X-ray equipment and apply Digital Dentistry technology to film, analyze the correct oral condition for routine and clinical exams for intensive treatments such as Implant, endodontic treatment, oral surgery, ...<\/p>\n\nX-ray CT film:<\/strong><\/em> provides 3-dimensional images detailing the entire jaw region structure; help assess the correct bone quality (thinness) and the number of bones, determine the lower jaw nerve, ... and especially in Implant surgery, X-ray film - CT helps choose the right position and Implant plug direction.<\/p>\n\nFilm X-ray panoramic:<\/strong><\/em> provides images showing the entire state of jawbone, teeth, periodontal; locate tooth decay, under tooth, root canal, infected tooth,<\/p>\n\nX-ray film of the skull inclination:<\/strong><\/em> for images of the status of the skull bone, very necessary in orthodontic orthodontics like braces.<\/p>\n","image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/service\/kham-rang-dinh-ky-a.jpg?t=1600937045","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/service\/kham-rang-dinh-ky-a.jpg?t=1600937045","tags":"tooth,dental examinations,periodic dental examinations","count_view":0,"seo_name":"periodic-dental-examinations","date_update":0,"date_created_format":"1744701793","meta_title":"","meta_desc":"","meta_keyword":"","price":false,"price_final":"1.000.000 đ","icon_svg":"","qr_code":"https:\/\/quaythuocyenphuong.biz.vn\/periodic-dental-examinations"},{"id":63280,"name":"Maternity Services","desc":"Pregnancy is a very important stage for the health of the mother and baby. In order for your baby to develop comprehensively from the time of birth in the womb to the time of birth, you need to choose the mode of conception and have the most professional monitoring.<\/p>\n","content":"Pregnancy is a very important stage for the health of the mother and baby. In order for your baby to develop comprehensively from the time of birth in the womb to the time of birth, you need to choose the mode of conception and have the most professional monitoring.<\/p>\n\n<img alt=\"Maternity Services\" src=\"\/datafiles\/30048\/upload\/images\/service\/dich-vu-sinh-san.jpg\" \/><\/p>\n\n- Directly consulted, consulted and monitored by obstetric and gynecological experts during pregnancy.<\/p>\n\n- Enjoy the full benefits of using pregnancy care services such as: ultrasound, examination with obstetricians and anesthesiologists, routine testing, fetal heart monitor, vaccination ...<\/p>\n\n- Ensure to capture all changes in the mother&#39;s body, detect and promptly handle risks and prevent adverse signs affecting the health of the mother and fetus<\/p>\n\n- Modern equipment and facilities with the best facilities in accordance with international 5-star medical service standards.<\/p>\n\n- Caesarean selected day, time, choose a good doctor.<\/p>\n\n- All necessary items for mother and baby such as newborn clothes, pacifiers, milking machines ... are well prepared.<\/p>\n\nWith 2 packages of caring and thoughtful care services, we are pleased to accompany you to vote until you give birth with quality, professional and responsible health services:<\/p>\n\n1. Maternity service package: Pregnant women can register the &quot;maternity&quot; package right from the first months of pregnancy (preferably after the examination, ultrasound and tests to make sure the fetus has entered Uterine).<\/p>\n\n2. Package delivery service: Pregnant women should sign up for the &quot;birth&quot; service starting at the 28th week of pregnancy to ensure the best care benefits.<\/p>\n","image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/sinh-san.jpg?t=1600937045","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/sinh-san.jpg?t=1601632575","tags":"maternity,maternity service,birth","count_view":0,"seo_name":"maternity-services","date_update":0,"date_created_format":"1744701793","meta_title":"","meta_desc":"","meta_keyword":"","price":false,"price_final":false,"icon_svg":"","qr_code":"https:\/\/quaythuocyenphuong.biz.vn\/maternity-services"},{"id":63279,"name":"X-ray Services","desc":"The clinic is open from 7:30 to 17:00 from Monday to Friday, and from 7:30 to 12:00 on Saturdays.&nbsp;Please make an appointment in advance to save time and ensure effective medical examination.<\/p>\n","content":"The clinic is open from 7:30 to 17:00 from Monday to Friday, and from 7:30 to 12:00 on Saturdays.<\/p>\n\nPlease make an appointment in advance to save time and ensure effective medical examination.<\/p>\n\nAt the hospital we offer the following X-ray services:<\/p>\n\nX-RAY SKIN<\/strong><\/p>\n\n1 Skull Skeleton (Straight \/ Tilt)<\/p>\n\n2 Skull bone scan (Tilt)<\/p>\n\n3 Shoot Schuller (P)<\/p>\n\n4 Shooting Schuller (T)<\/p>\n\n5 Jaw Joint (P) (Straight \/ Tilt)<\/p>\n\n6 Jaw Joint (T) Joint (Straight \/ Tilt)<\/p>\n\n7 Lower Jaw (P) (Diagonal)<\/p>\n\n8 Lower Jaw (T) (Diagonal)<\/p>\n\n9 Shooting Sinus (Blondeau-Hizt)<\/p>\n\n10 Posture Skull Shooting (TOWNE)<\/p>\n\n11 Primary Nose (Straight \/ Tilt)<\/p>\n\nX-RAY COLLEGE LIVE<\/strong><\/p>\n\n12 Cervical Spine (Straight \/ Tilt)<\/p>\n\n13 Cervical Spine (Tilt)<\/p>\n\n14 Cervical Spine (Straight \/ Tilt, Diagonal)<\/p>\n\n15 Chest Spine (Straight \/ Tilt)<\/p>\n\n16 Shooting backbone (Straight \/ Tilt)<\/p>\n\n17 Lumbar Spine (End \/ Back)<\/p>\n\n18 Lumbar Spine Imaging (X-Cross, X-Cross)<\/p>\n\nX-RAY<\/p>\n\n19 Take a Heart Shot straight<\/p>\n\n20 Apicolordotic (Apicolordotic)<\/p>\n\n21 Cardiogram (Straight \/ Tilt)<\/p>\n\n22 Chest Bone Injury<\/p>\n\nX-rays of FRENCH FRAME<\/p>\n\n23 Shoulder joint (P) (Straight \/ Tilt)<\/p>\n\n24 Shoulder joint (T) (Straight \/ Tilt)<\/p>\n\n25 Clavicle Shooting (P)<\/p>\n\n26 Clavicle Shooting (T)<\/p>\n\n27 Shooting Arms (P) (Straight \/ Tilt)<\/p>\n\n28 Shooting Arms (T) (Straight \/ Tilt)<\/p>\n\n29 Elbow Joint (P) (Straight \/ Tilt)<\/p>\n\n30 Elbow Joint (T) (Straight \/ Tilt)<\/p>\n\n31 Forearm Shooting (P) (Straight \/ Tilt)<\/p>\n\n32 Forearm (T) Shooting (Straight \/ Tilt)<\/p>\n\n33 Wrist Joint (P) (Straight \/ Tilt)<\/p>\n\n34 Wrist Joint (T) (Straight \/ Tilt)<\/p>\n\n35 Shooting Hands (P) (Straight \/ Tilt)<\/p>\n\n36 Shooting Hands (T) (Straight \/ Tilt)<\/p>\n\n37 Femur (P) (Straight \/ Tilt)<\/p>\n\n38 Laparoscopy (T) (Straight \/ Tilt)<\/p>\n\n39 Knee Joint (P) (Straight \/ Tilt)<\/p>\n\n40 Knee Joint (T) (Straight \/ Tilt)<\/p>\n\n41 Shin Joint (P) (Straight \/ Tilt)<\/p>\n\n42 Shooting the Calf Joint (T) (Straight \/ Tilt)<\/p>\n\n43 Ankle Joint (P) (Straight \/ Tilt)<\/p>\n\n44 Ankle Joint (T) (Straight \/ Tilt)<\/p>\n\n45 Foot Joint (P) (Straight \/ Tilt)<\/p>\n\n46 Foot Joint (T) (Straight \/ Tilt)<\/p>\n\n47 Heelbone (P) (Straight \/ Tilt)<\/p>\n\n48 Heelbone (T) (Straight \/ Tilt)<\/p>\n\n49 Abdominal Shooting lying unprepared<\/p>\n\n50 Stand still abdomen not prepared<\/p>\n\n51 Urinary System (KUB)<\/p>\n\n52 Tilt the lumbar spine<\/p>\n\nX-RAY FRENCH FRAME, EXTRACT, BONE SAME, PUT<\/strong><\/p>\n\n53 Pelvic Shooting (Straight)<\/p>\n\n54 Pelvic Shooting (Straight \/ Tilt)<\/p>\n\n55 Pelvic Shooting (Outlet, Inlet)<\/p>\n\n56 Crotch (P) (Straight \/ Tilt)<\/p>\n\n57 Crotch Joint (T) (Straight \/ Tilt)<\/p>\n\n58 Take the Coccyx (Straight \/ Tilt)<\/p>\n","image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/service\/dich-vu-x-quang.jpg?t=1600937045","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/service\/dich-vu-x-quang.jpg?t=1600937045","tags":"x-ray,x-ray services","count_view":0,"seo_name":"x-ray-services","date_update":0,"date_created_format":"1744701793","meta_title":"","meta_desc":"","meta_keyword":"","price":false,"price_final":"1.000.000 đ","icon_svg":"","qr_code":"https:\/\/quaythuocyenphuong.biz.vn\/x-ray-services"},{"id":63278,"name":"Ear – Nose – Throat","desc":"Our clinic is the first clinic specialized in Otolaryngology with the first modern equipment in Vietnam. Internal and outpatient examination and treatment of ENT diseases and head and neck diseases with high quality medical services.<\/p>\n","content":"Our clinic is the first clinic specialized in Otolaryngology with the first modern equipment in Vietnam. Internal and outpatient examination and treatment of ENT diseases and head and neck diseases with high quality medical services.<\/p>\n\n<img alt=\"Ear – Nose – Throat\" src=\"\/datafiles\/30048\/upload\/images\/service\/tai-mui-hong.jpg\" \/>The clinic implements after-hours examination (service examination) according to the following time frames:<\/p>\n\n+ From Monday - Friday: 6h - 7h; 11h - 13h; 16h - 19h<\/p>\n\n+ Saturday and Sunday: 7h - 19h<\/p>\n\nThe clinic has implemented the appointment forms: direct phone call, registration for medical examination through the switchboard 08 1080 (fee: 2,000 VND \/ minute).<\/p>\n\nYou can call directly to the switchboard number 08 1080 for specific instructions or you can call the Department of Otolaryngology at the clinic for more details.<\/p>\n","image_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/images\/service\/tai-mui-hong-a.jpg?t=1600937045","image_thumb_url":"https:\/\/quaythuocyenphuong.biz.vn\/datafiles\/60086\/upload\/thumb_images\/service\/tai-mui-hong-a.jpg?t=1600937045","tags":"ear,nose,throat","count_view":0,"seo_name":"ear-nose-throat","date_update":0,"date_created_format":"1744701793","meta_title":"","meta_desc":"","meta_keyword":"","price":false,"price_final":"200.000 đ","icon_svg":"","qr_code":"https:\/\/quaythuocyenphuong.biz.vn\/ear-nose-throat"}]},"widget_13902077":{"content_data":{"content":"Statistics<\/span><\/span>"}},"widget_13902082":{"content_data":{"content":"Social Profiles<\/span>"}},"widget_13902086":{"content_data":{"content":"Designed by P.A Viet Nam\n<\/span>"}},"widget_8178047":{"content_data":{"content":""}},"widget_8178055":{"content_data":{"content":"Product Code:<\/span>"}},"widget_8178058":{"content_data":{"price_final":"Contact"}},"widget_8178067":{"content_data":{"content":"Product Code:<\/span>"}},"widget_8178070":{"content_data":{"content":"Product Code:<\/span>"}},"widget_8178082":{"content_data":{"content":"<\/span>"}},"widget_8178063":{"content_data":{"content":"Tiết kiệm:"}},"widget_8178078":{"content_data":{"content":""}},"widget_8178080":{"content_data":{"content":"add to cart&nbsp;"}},"widget_8178083":{"content_data":{"content":"<\/span>"}},"widget_8178079":{"content_data":{"content":""}},"title_page":"Sản phẩm","relate_object_id":3567003}

GAVIX

RELATED PRODUCTS

APITIM

ATORLIP 10

ATORLIP 20

GLIRITDHG 500/2.5

COPERIL PLUS

ABOUt us

services

Statistics

Social Profiles

Designed by P.A Viet Nam